ACB
Aristotle Capital Boston’s Supernus Pharmaceuticals SUPN Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.5M | Sell |
808,395
-64,293
| -7% | -$2.03M | 1.3% | 25 |
|
2025
Q1 | $28.6M | Sell |
872,688
-203,180
| -19% | -$6.65M | 1.43% | 21 |
|
2024
Q4 | $38.9M | Sell |
1,075,868
-118,358
| -10% | -$4.28M | 1.44% | 20 |
|
2024
Q3 | $37.2M | Sell |
1,194,226
-8,940
| -0.7% | -$279K | 1.23% | 28 |
|
2024
Q2 | $32.2M | Buy |
1,203,166
+63,320
| +6% | +$1.69M | 1.08% | 35 |
|
2024
Q1 | $38.9M | Sell |
1,139,846
-19,982
| -2% | -$682K | 1.18% | 29 |
|
2023
Q4 | $33.6M | Sell |
1,159,828
-28,153
| -2% | -$815K | 1.03% | 38 |
|
2023
Q3 | $32.8M | Buy |
1,187,981
+26,034
| +2% | +$718K | 1.06% | 35 |
|
2023
Q2 | $34.9M | Buy |
1,161,947
+6,798
| +0.6% | +$204K | 1.05% | 34 |
|
2023
Q1 | $41.9M | Buy |
1,155,149
+28,268
| +3% | +$1.02M | 1.29% | 20 |
|
2022
Q4 | $40.2M | Sell |
1,126,881
-30,672
| -3% | -$1.09M | 1.27% | 22 |
|
2022
Q3 | $39.2M | Sell |
1,157,553
-110,187
| -9% | -$3.73M | 1.32% | 15 |
|
2022
Q2 | $36.7M | Buy |
1,267,740
+9,673
| +0.8% | +$280K | 1.09% | 26 |
|
2022
Q1 | $40.7M | Sell |
1,258,067
-27,805
| -2% | -$899K | 1.03% | 30 |
|
2021
Q4 | $37.5M | Sell |
1,285,872
-32,237
| -2% | -$940K | 0.88% | 43 |
|
2021
Q3 | $35.2M | Buy |
1,318,109
+256,456
| +24% | +$6.84M | 0.82% | 48 |
|
2021
Q2 | $32.7M | Buy |
1,061,653
+88,360
| +9% | +$2.72M | 0.75% | 54 |
|
2021
Q1 | $25.5M | Sell |
973,293
-48,333
| -5% | -$1.27M | 0.57% | 82 |
|
2020
Q4 | $25.7M | Sell |
1,021,626
-50,826
| -5% | -$1.28M | 0.61% | 74 |
|
2020
Q3 | $22.4M | Buy |
1,072,452
+44,614
| +4% | +$930K | 0.65% | 63 |
|
2020
Q2 | $24.4M | Buy |
1,027,838
+287,199
| +39% | +$6.82M | 0.74% | 50 |
|
2020
Q1 | $13.3M | Sell |
740,639
-16,864
| -2% | -$303K | 0.57% | 72 |
|
2019
Q4 | $18M | Buy |
757,503
+13,511
| +2% | +$320K | 0.5% | 88 |
|
2019
Q3 | $20.4M | Buy |
743,992
+639,961
| +615% | +$17.6M | 0.6% | 72 |
|
2019
Q2 | $3.44M | Buy |
+104,031
| New | +$3.44M | 0.11% | 123 |
|